NFKB1 and Alzheimer disease: In this study, we evaluated whether AA treatment downregulates Th1- and Th2-related cytokine levels and reduces NF-κB, p-Akt, and MAPK signaling 1evels in a DNCB-induced AD animal model (Figure 6 and Figure 7).